Cao Pharmaceuticals Inc.
  • Home
  • About
    • Background
    • Mission
    • Leadership
  • Products
    • Lead Drug
    • Unique Advantages
    • Pipeline
  • Contact
  • Investor Relations
Picture
Investment opportunity in the Phase II studies planned for Q2 of 2020 is now in the open period.

For investment information please contact V.P. of Investment Relations Chris Wood
[email protected]
Proudly powered by Weebly
  • Home
  • About
    • Background
    • Mission
    • Leadership
  • Products
    • Lead Drug
    • Unique Advantages
    • Pipeline
  • Contact
  • Investor Relations